Guidance language shifted to a more specific projection of 15%-20% operating expense growth for 2026, compared to less specific spending outlook in Q3. Management's confidence increased, underpinned ...

Management targets Q1 2026 subscription revenue to grow at a mid-single-digit percentage rate on an FX-neutral year-over-year basis.

I know it’s not really sexy to talk about prevention, education, but that’s our main goal here,” explained Léa Clermont-Dion, the founder of the “On s’écoute” campaign, aimed at preventing sexual ...

GeniTech, the smart-driving chip division of the Chinese EV startup known for its new energy vehicles, has reached an ...

Despite a significant drop in revenue, WAVE Life Sciences Ltd (WVE) showcases promising clinical data and a strong cash position to fuel future growth.

Q4 2025 Management View Charles Gayer, CEO, emphasized, "We closed 2025 with strong momentum, delivering full-year ORLADEYO revenue of $601.8 million. That was up 38% for the year and 43% when you ...

Q4 2025 Management View CEO Michael Castagna emphasized the transformation of MannKind, stating, "Tyvaso DPI has transformed both United Therapeutics and MannKind's future to fund our respective ...